Stock Updates

A look at a High Market Cap Stock: St. Jude Medical Inc., STJ

St. Jude Medical Inc., STJ is in the exchange NYSE and its industry is Medical Appliances & Equipment in the sector of Healthcare. Based in USA, St. Jude Medical Inc., STJ  has a market cap of 22186.09. Since its IPO date on the 12/7/1989, St. Jude Medical Inc., STJ performance year to date is 27.98%. Today St. Jude Medical Inc., STJ has gained -0.23%, with a current price of 77.98.

Ownership of the company is 0.10% for insider ownership while institutional ownership is 83.30%. The management of the company have seen the company have a payout ratio of 51.40%. Return of assets are at 5.40%, with return on investment at 9.30%.

In terms of debt levels and profit levels, St. Jude Medical Inc., STJ is seeing a long-term debt/equity of 1.27. While Total debt/equity is 1.42. With a profit margin of 11.40%, this is combined with a gross margin of 67.10%, and operating margin of 16.10%. St. Jude Medical Inc. ability to meet debt levels, with a current ratio of 1.7, while the quick ratio is 1.2.

For the last year St. Jude Medical Inc., STJ has seen a EPS growth of -11.10%. A performance for the year of 18.23%. The 52-week high is -6.81%, and the 52-week low is 61.90%. The average volume for St. Jude Medical Inc., STJ is 1422465.

With a target price of 79.7, can St. Jude Medical Inc., STJ reach this target? Looking at the value indicators of St. Jude Medical Inc., STJ. St. Jude Medical Inc. has a P/E of 33.86 and a forward P/E of 17.65. Perhaps the more useful indicator than P/E, is PEG which has a value of 2.98. St. Jude Medical Inc. also has a P/S and a P/B of 3.83 and 5.18 respectively. For P/cash, St. Jude Medical Inc. has a value of 55.74, while it is 43.76 for P/free cash flow.

At the current price of 77.98, St. Jude Medical Inc. has a dividend yield of 1.59%. We see a return on equity of 16.10%.

Looking more long-term St. Jude Medical Inc., is projected to get an EPS growth for the next five years of 11.38%. In the short-term an EPS growth of 8.95% in the next year is forecasted. This is after a EPS growth of -11.10% for this year and for the last five years a 2.30% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment